Invectys Therapeutics
Alix Jacquier has a strong background in research and pharmaceuticals, specializing in cancer immunology and innovative immunotherapies. They have experience in project and team management, as well as various lab skills including cell culture, flow cytometry, and protein purification. With a Research Doctorate in Cancer and Immunology, Alix has worked in various internships and positions at companies like Invectys, CEA, and Servier, showcasing their expertise in the field.
This person is not in any offices
Invectys Therapeutics
Invectys is a biopharmaceutical company focused on the development of innovative immunotherapy approaches to treat cancers. It was founded in 2010 by Pierre Langlade Demoyen and Simon Wayne-Hobson and is based in Paris.Invectys develops a novel approach to mobilizing and restoring the anti-tumor capacity of the immune system of cancer patients.This allows virtually all cancers to be targeted. Invectys focuses its efforts on two highly prevalent tumor antigens: the nearly-universal tumor antigen telomerase that is critical to uncontrolled cell growth, and the HLA-G immune checkpoint expressed in over 50% of cancers.